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Effect sizes from psychosocial interventions are typically lower for delusions than 
hallucinations (e.g. Van der Gaag et al, 2014), highlighting a need to improve and extend 
psychological therapies for individuals with delusions. Chadwick and colleagues (see 
Chadwick et al., 2005; Chadwick, 2014) developed mindfulness-based therapy for people 
with psychosis. Data from randomised controlled trials indicate benefits of mindfulness on 
total psychotic symptoms (Louise et al., 2018) and on voice-specific outcomes (e.g. 
Chadwick et al., 2016) – but no data assess persecutory delusions specifically. Moreover, 
whilst researchers have evaluated mindfulness groups for people who hear voices, no 
published study assesses mindfulness groups specifically for people with persecutory 
delusions. Indeed, in the UK, whilst voices groups are routinely offered both by NHS services 
and mental health charities to facilitate peer-support, this is not so for persecutory 
delusions, and clinicians express concerns about the feasibility and benefit of bringing 
together in groups people whose primary symptom concerns fear and mistrust of others.  
The present study is a single-centre pilot randomised controlled trial for people with 
persecutory delusions of group mindfulness plus standard care versus standard care alone. 
The study aims were to: (1) assess recruitment and retention; (2) assess acceptability of the 
group mindfulness intervention; (3) generate an indicative effect size on the pre-set primary 
outcome (depression); (4) monitor possible harmful effects (adverse events and 
deterioration in depression); (5) explore group process. 
Methods   
27 people with a diagnosis of a Schizophrenia Spectrum Disorder including a current 
distressing persecutory delusion were randomised to receive either group mindfulness 
based therapy (12 sessions) alongside treatment as usual (TAU: n=14) or TAU alone (n=13).  
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The pre-set primary outcome was depression, measured using the BDI II (Beck et al., 1996) 
at baseline and post intervention.  Depression was chosen as the primary outcome because 
it has been shown to predict the persistence of persecutory delusions over time (Fowler et 
al., 2011), is conceptually aligned with the aims in mindfulness for psychosis (Chadwick, 
2014), and is valued by service users. Mindfulness participants also completed the 7-item 
Satisfaction with Therapy Scale (Freeman et al., 2016). To explore group process, post-
treatment all mindfulness participants rank-ordered by subjective importance to group 
participation seven statements relating to non-specific therapeutic factors (catharsis, hope, 
universality, interpersonal learning, self-discovery, cohesion, altruism) and an eighth relating 
to mindfulness specifically (see Chadwick et al., 2009).  The research assistant assessed 
therapy fidelity immediately after six randomly chosen sessions; participants completed 
checklists indicating adherence to four key elements of the session protocol.  
Results 
The consort diagram (Figure 1) shows the trial profile.  Participant characteristics at 
baseline were broadly equivalent in the two arms of the study.  All participants were taking 
medication, and the majority were single (85%), unemployed (56%) and male (78%) of 
varying ethnicity (81% White British; 11% White Other; 4% Indian; 4% Pakistani), with a 
diagnosis of Paranoid Schizophrenia (67%).    
Recruitment, retention and acceptability  
Of the 73 individuals put forward for the study, 37% consented, 38% declined, and 
25% were ineligible.  In line with good practice recommendations for pilot studies (Julious, 
2005), the study achieved its aim to retain a minimum of 12 participants per arm and did so 
within its pre-set recruitment timeframe (28 weeks).  Study retention rate was high (96%), 
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with one drop-out from TAU and none from mindfulness.  Data completeness for 
participants retained in the study was 90% at post therapy.  All participants in the treatment 
arm attended at least 50% of therapy sessions (range 6-12, mean 10 sessions), therapy 
satisfaction was high (modal score of 4-5/5 on each of the seven therapy satisfaction items).  
All participant ratings indicated 100% adherence to the group therapy protocol for six 
randomly sampled sessions.  Overall, these data attest to the feasibility and acceptability of 
the intervention.   
Depression and group process 
A small effect size on depression was found in favour of the mindfulness intervention 
(d = 0.2, 95% CI -0.95,0.85).  In the treatment arm, mean baseline BDI score was 23.1 (SD = 
16.7), and post therapy mean was 15.2 (SD=13.6).  In TAU, mean baseline BDI score was 
25.9 (SD = 12.4), and post therapy mean was 22.9 (SD = 12.2). Eight participants (64%) 
receiving mindfulness showed a clinically meaningful reduction in depression pre-post 
intervention and none showed a clinically meaningful increase (MCID on the BDI was set at 
5).  In TAU, six (46%) showed a clinically meaningful reduction and one (8%) a clinically 
meaningful increase.  There were no serious adverse events or hospitalisations during the 
course of the study.  Data from subjective ratings of therapeutic factors showed learning 
mindfulness and altruism (“Helping others and being important in their lives”) to be jointly 
ranked as the subjectively most important aspects of group participation.  
Discussion 
All 14 mindfulness participants attended at least 6 sessions (‘completers’), with no drop 
out, and satisfaction with mindfulness was uniformly high.  A small effect was found on 
depression (primary outcome) and 64% who received the mindfulness group showed a 
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clinically meaningful reduction in depression pre-post therapy. There were no adverse 
events associated with participation in mindfulness groups, or the wider study, and none of 
the mindfulness participants showed a clinically meaningful deterioration in depression (one 
person in TAU did).  
The study sheds light on the therapeutic process, highlighting for the first time in 
research on mindfulness for psychosis the subjective importance of altruistic connection 
with others – this finding is particularly striking in a study of people with persecutory 
delusions. The study has limitations. As befits a pilot trial, the sample size was intentionally 
small and not powered to detect statistically significant effects, and there was no follow up.  
Mindfulness practice was not formally assessed between sessions and there was no active 
control condition.   
In conclusion, the pilot study showed it is possible to recruit and retain people with 
current persecutory delusions into a group mindfulness study and the intervention was 
found to be safe, acceptable, and to reduce depressive symptoms.   
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Assessed for eligibility (n= 73) 
Excluded (n= 46) 
♦ Not meeting inclusion criteria (n= 18) 
- Diagnosis outside criteria (Emotionally 
Unstable PD; Bipolar; Severe LD) 
- Discharged from SABP during contact 
- Does not feel they are unwell/paranoid – 
not eligible due to PSYRATS score 
- Undergoing Psychology input 
- High risk of violence in group 
♦   Declined to participate (n= 17) 
- Reasons given: 
- Disliked group setting (listening to other 
experiences increase own paranoia; 
Anxiety owing to side effects of 
medication – pacing etc) 
- Prefer to focus on completing 
courses/goals unable to do hen unwell/ 
not wanting to ‘rock the boat’ 
- Very stuck on previous therapies not 
working ‘why would this be different’ 
♦   Other reasons: Unable to make contact 
(n= 11) 
 
Analysed (n=13)  
 Excluded from analysis (give reasons) (n=0) 
Lost to follow-up (withdrew from study) (n= 1) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to treatment as usual (n= 13) 
 Received treatment as usual (n= 13 ) 
 Did not receive allocated intervention (n=  0) 
Lost to follow-up (n= 0) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to intervention (n= 14) 
 Received allocated intervention (n= 14  ) 
 Did not receive allocated intervention (n= 0  ) 
Analysed (n=14)  





Randomized (n= 27) 
Enrollment 
9 
 
 
 
 
